← Back to Patent Explorer
US3955928A Expired / Lapsed US ⏱️ 0.0 years remaining

Pregnancy test

Assignee: Individual
•
Filing: 1975-08-15
•
Granted: 1976-05-11
•
Expires: 1995-08-15
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A process for determining pregnancy wherein the concentration of estrogen steroids in the urine is evaluated by spectrophotometric measurement.

Inventors

  • 👤 Hugh Yee

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 23:51
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/74; G01N33/743; Y; Y10; Y10T; Y10T436/00; Y10T436/20; Y10T436/200833; Y10T436/203332

Claims Analysis

Total Claims: 16
Claim 1
Independent Claim 59 words
A process for determining pregnancy by measurement of the estrogens present in urine, comprising the steps of: a. separating the estrogen steroids from the urine; b. hydrolyzing the separated estrogen steroids; c. extracting the estrogen steroids from the urine; d. forming the estrogen steroid extract into chromogens; and e. evaluating the concentration of the estrogen steroids by spectrophotometric measurements.
Claim 2
Dependent Claim 59 words
A process for determining pregnancy by measurement of the estrogens present in urine, comprising the steps of: a. separating the estrogen steroids from the urine; b. hydrolyzing the separated estrogen steroids; c. extracting the estrogen steroids from the urine; d. forming the estrogen steroid extract into chromogens; and e. evaluating the concentration of the estrogen steroids by spectrophotometric measurements.
Claim 3
Dependent Claim 26 words
The process defined in claim 1 wherein the step of separating the estrogen steroids from the urine is accomplished by precipitation with ammonium sulfate and centrifugation.
Claim 4
Dependent Claim 34 words
The process of claim 1 wherein the step of separating the estrogen steroids from the urine is accomplished in a neutral ion-exchange resin chromotography column and then eluted from the resin column with methanol.
Claim 5
Dependent Claim 25 words
The process of claim 1 wherein the step of hydrolyzing the separated estrogen steroids is performed with an enzyme mixture of beta-glucuronidase and phenol sulfatase.
Claim 6
Dependent Claim 21 words
The process of claim 1 wherein the step of hydrolyzing the separated estrogen steroids is performed in an acetate buffered solution.
Claim 7
Dependent Claim 30 words
The process of claim 1 wherein the extracting of the estrogen steoids from the urine is effected with ethyl-ether, the ether then being evaporated to yield an estrogen steroid residue.
Claim 8
Dependent Claim 47 words
The process as defined in claim 1 wherein the step of evaluating the concentration of the estrogen steroids is performed by spectrophotometric measurement at wavelengths of the order of 520-550 nm and comparison of the absorbance values thereby obtained with those of estrogen standards of known concentrations.
Claim 9
Dependent Claim 36 words
The process of claim 1 wherein the step of separating the estrogen steroids from the urine is effected by solvent extraction with a 3:1 ratio ethy ether-ethanol solvent mixture of the urine sample with ammonium sulfate.
Claim 10
Dependent Claim 23 words
The process defined in claim 8 wherein after the chromogen forming there is included the further step of buffering with an EDTA-borate solution.
Claim 11
Dependent Claim 42 words
The process of claim 1 wherein the step of forming chromogens is accomplished by the reaction of the estrogen steroids by a coupling of the phenolic group of estrogen steroid molecules with a conjugating agent, followed by the further step of oxidation.
Claim 12
Dependent Claim 13 words
The process of claim 10 wherein the conjugating agent comprises 3-methyl-2-benzothiazolinone hydrazone hydrochloride.
Claim 13
Dependent Claim 11 words
The process of claim 10 wherein the conjugating agent comprises 4-aminoantipyrine.
Claim 14
Dependent Claim 17 words
The process defined in claim 10 wherein the further step of oxidation is accomplished with ceric salts.
Claim 15
Dependent Claim 23 words
The process defined in claim 10 wherein the further step of oxidation of the estrogen steroids is accomplished by treatent with ferric salts.
Claim 16
Dependent Claim 19 words
The process defined in claim 10 wherein the further step of oxidation is accomplished by treatment with ammonium persulfate.

References Cited (Backward Citations)

US3615229A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1979-05-11 1979-11-10 1980-05-11 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1983-05-11 1983-11-10 1984-05-11 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1987-05-11 1987-11-10 1988-05-11 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag